RAYOS

Drug Horizon Pharma plc
Total Payments
$4.7M
Transactions
47,302
Doctors
9,357
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2023 $111.81 6 2
2022 $301,624 5,331 2,331
2021 $365,162 6,261 2,592
2020 $425,572 6,101 2,203
2019 $1.0M 7,853 2,089
2018 $1.2M 10,744 2,677
2017 $1.4M 11,006 2,899

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $3.5M 2,013 73.9%
Food and Beverage $815,741 44,109 17.2%
Travel and Lodging $217,028 1,014 4.6%
Unspecified $177,253 12 3.7%
Grant $15,825 2 0.3%
Consulting Fee $10,730 1 0.2%
Education $517.00 151 0.0%

Payments by Type

General
$4.6M
47,290 transactions
Research
$177,253
12 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
HNZP-PRE-IIT-004 Horizon Pharma plc $177,253 0

Top Doctors Receiving Payments for RAYOS — Page 375

Doctor Specialty Location Total Records
, DPM Primary Podiatric Medicine San Gabriel, CA $2.57 1
, D.P.M Podiatrist Phoenix, AZ $2.14 1
, MD Rheumatology Louisville, KY $2.14 1
, MD Orthopaedic Surgery Flint, MI $2.10 1
, MD Internal Medicine West Hollywood, CA $1.64 1
, MD Internal Medicine Lexington, KY $1.19 1
, D.P.M Podiatrist Bridgeport, CT $1.07 1
, M.D Geriatric Medicine Los Angeles, CA $0.37 1
«1…373374375

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $4.7M
  • Total Doctors 9,357
  • Transactions 47,302

About RAYOS

RAYOS is a drug associated with $4.7M in payments to 9,357 healthcare providers, recorded across 47,302 transactions in the CMS Open Payments database. The primary manufacturer is Horizon Pharma plc.

Payment data is available from 2017 to 2023. In 2023, $111.81 was paid across 6 transactions to 2 doctors.

The most common payment nature for RAYOS is "Honoraria" ($3.5M, 73.9% of total).

RAYOS is associated with 1 research study, including "HNZP-PRE-IIT-004" ($177,253).